Molecular Partners Ag Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 122.33M-69.02M-61.43M
Share-based Compensation 2.45M3.24M4.43M5.28M5.80M4.67M
Cash from Operations -1.20M-32.06M-98.64M123.07M-65.70M-67.35M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 2.49M3.19M2.78M2.48M2.69M2.69M
Change in Working Capital
Change in Receivables 49.91M-0.61M-25.35M26.22M-1.04M-0.39M
Change in Account Payables -0.27M3.76M1.80M-5.54M-0.90M0.60M
Change in Taxes 0.02M-0.01M0.00M0.00M
Investing Activities
Capital Expenditures 1.04M1.61M1.01M1.22M0.64M0.80M
Cash from Investing Activities -19.97M-24.05M-24.12M-104.97M49.70M46.02M
Financing Activities
Change in Capital Stock
Shares Issued 1.02M125.67M55.84M0.26M0.03M19.71M
Misc.
Cash from Financing Activities -0.23M125.22M54.86M-1.63M-1.30M16.41M
Exchange Rate Effect -2.01M-4.94M0.76M0.27M-5.68M1.02M
Change in Cash -23.40M64.17M-67.14M16.75M-22.98M-3.90M
Free Cash Flow -2.24M-33.66M-99.65M121.85M-66.34M-68.15M
Net Cash Flow -21.40M69.10M-67.90M16.48M-17.30M-4.92M